Association of Low Prognostic Nutritional Index Score with Lymph Node Metastasis in Breast Cancer Patients, Unlike Hemoglobin-Albumin-Lymphocyte-Platelet Score - Top-Institutions - MDSpire

Association of Low Prognostic Nutritional Index Score with Lymph Node Metastasis in Breast Cancer Patients, Unlike Hemoglobin-Albumin-Lymphocyte-Platelet Score

  • By

  • Weihua Wen

  • Litao Jin

  • Yuyang Yang

  • Jianjuan Li

  • April 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Cancer Oncology
    • Cancer Immunology
    • Nutritional Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Cancer Immunology
    • Clinical Nutrition

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer Oncology
    • Cancer Immunology
    • Nutritional Science

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Breast Cancer Research
    • Immunology
    • Clinical Nutrition

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Breast Cancer Oncology
    • Cancer Immunology
    • Nutritional Oncology

Original Source(s)

Association of Low Prognostic Nutritional Index Score with Lymph Node Metastasis in Breast Cancer Patients, Unlike Hemoglobin-Albumin-Lymphocyte-Platelet Score

  • by Weihua Wen, Litao Jin, Yuyang Yang, Jianjuan Li

  • April 27, 2026

Related Content

Auricular acupuncture for insomnia in female patients with non-metastatic breast cancer: study protocol for a multicenter, randomized, controlled clinical trial

Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models